- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 5.86M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$214.98K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$281.94K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.59K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $7.92K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $364.78K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $646.72K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$1.78M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.32M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $197.4K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $450.88K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $39.35M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.35M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $39.35M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.35M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $81.98K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $29.53K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $39.47M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $72.95M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.07 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.08 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$29.12K |
| Net Income | Q1 2026 · Mar 31, 2025 | $472.59K |